Novel Antibiotics Targeting Bacterial Replicative DNA Polymerases.

Area of Science:

• Microbiology
• Molecular Biology
• Drug Discovery

Background:

• Multidrug resistance poses a significant global health threat, necessitating novel antibiotic development.
• Current antibiotics primarily target RNA transcription and translation, with DNA replication inhibition being indirect.
• Antiviral therapies successfully target viral replicases, highlighting a gap in antibacterial strategies.

Purpose of the Study:

• To review past and current research on inhibiting bacterial DNA replication.
• To explore the potential of bacterial DNA polymerase inhibitors as novel antibiotic targets.

Main Methods:

• Literature review of existing studies on bacterial DNA replication inhibitors.
• Analysis of compounds targeting bacterial replicative polymerases (PolC and DnaE).

Main Results:

• A growing number of compounds targeting the bacterial replisome have emerged in the last two decades.
• Several inhibitors of bacterial DNA polymerases PolC and DnaE have been identified.
• One DNA polymerase inhibitor has advanced to clinical trials.

Conclusions:

• Direct inhibition of bacterial DNA replication, particularly targeting DNA polymerases, represents a promising avenue for new antibiotics.
• Bacterial DNA polymerase inhibitors offer a potential solution to combatting multidrug-resistant infections.